Riding on Modinomics hopes, India’s indebted companies rush to lock in funds
MUMBAI (Reuters) - Several private Indian firms want to pay off debts by raising up to $5 billion this year through share sales, emboldened by a surge in the stock...
Home > Reviews
All Stories
Infosys running out of time to name new CEO as president quits
By Nivedita Bhattacharjee and Sumeet Chatterjee MUMBAI (Reuters) - India's second largest IT services exporter Infosys Ltd is under pressure to bring in a new chief executive soon to check...
India’s Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources
MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a...
India’s Sun Pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.: sources
MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States, after completing a...
India’s drug inspectors hard-pressed to scrutinize factories
MUMBAI (Reuters) - An Indian drugs regulator is among the first to admit that oversight of the nation's huge pharmaceutical industry can be patchy. G.L. Singhal, chief regulator of northern...
Banks, issuers look to Indian election to end IPO drought
MUMBAI (Reuters) - After waiting nearly two years, India's GMR Energy plans to file an IPO prospectus in coming days to raise about $250 million, sources with direct knowledge of...
Banks, issuers look to Indian election to end IPO drought
MUMBAI (Reuters) - After waiting nearly two years, India's GMR Energy plans to file an IPO prospectus in coming days to raise about $250 million, sources with direct knowledge of...
FDA bans imports from Sun Pharma plant in India crackdown
MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Sun Pharmaceutical Industries Ltd's plant at Karkhadi in the western state of Gujarat,...
Carlyle, Advent, others in hunt for HP’s MphasiS stake: sources
MUMBAI (Reuters) - Private equity giants Carlyle Group LP and Blackstone Group LP as well as Indian outsourcers L&T; Infotech and Tech Mahindra Ltd, are lining up bids for Hewlett-Packard...
India’s Sun Pharma in talks to buy Sweden’s Meda for $5-$6 billion: sources
MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's Meda AB for between $5 billion and $6 billion to boost its generics business in developed...